Sfoglia per Rivista  HEPATOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 64 a 83 di 123
Titolo Data di pubblicazione Autore(i) File
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 1-gen-2009 Aghemo, A.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; De Nicola, S.; Colombo, M.
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry 1-gen-2023 Slooter, Charlotte D; van den Brand, Floris F; Lleo, Ana; Colapietro, Francesca; Lenzi, Marco; Muratori, Paolo; Kerkar, Nanda; Dalekos, George N; Zachou, Kalliopi; Lucena, M Isabel; Robles-Díaz, Mercedes; Di Zeo-Sánchez, Daniel E; Andrade, Raúl J; Montano-Loza, Aldo J; Lytvyak, Ellina; Lissenberg-Witte, Birgit I; Maisonneuve, Patrick; Bouma, Gerd; Macedo, Guilherme; Liberal, Rodrigo; de Boer, Ynto S
Large liver cell change in hepatitis B virus-related liver cirrhosis 1-gen-2009 Kim, H.; Oh, B. K.; Roncalli, M.; Park, C.; Yoon, S. M.; Yoo, J. E.; Park, Y. N.
Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver‐Related Mortality Is Higher in Males? 1-gen-2021 Lleo, Ana; Hirschfield, Gideon M.
Letter to the Editor: might denosumab fit in PBC treatment? 1-gen-2019 Lleo, A; Ma, X; Gershwin, Me; Invernizzi, P
Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment? 1-gen-2020 Lleo, Ana; Xiong, Ma; Gershwin, M. Eric; Invernizzi, Pietro
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients 1-gen-2014 Quagliata, Luca; Matter, Matthias S; Piscuoglio, Salvatore; Arabi, Leila; Ruiz, Christian; Procino, Alfredo; Kovac, Michal; Moretti, Francesca; Makowska, Zuzanna; Boldanova, Tujana; Andersen, Jesper B; Hämmerle, Monika; Tornillo, Luigi; Heim, Markus H; Diederichs, Sven; Cillo, Clemente; Terracciano, Luigi M
Low Rates of Naturally Occurring Resistant Variants to the NS5A Inhibitor Daclatasvir in HCV-1 Null Responders 1-gen-2013 Galmozzi, E; Aghemo, A; Colombo, M
Males with primary biliary cirrhosis manifest enhanced rates of Y chromosome loss in peripheral white blood cells 1-gen-2008 Pasini, S.; Miozzo, M.; Bianchi, I.; Monti, V.; Rizzotto, E. R.; Floreani, A.; Colombo, M.; Selmi, C.; Podda, M.; Gershwin, M. E.; Invernizzi, P.
Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma 1-gen-2002 Roncalli, Massimo; Bianchi, Paolo; Bruni, Barbara; Laghi, Luigi; Destro, Annarita; Di Gioia, Sonia; Gennari, Leandro; Tommasini, Maurizio; Malesci, Alberto Carlo Piero; Coggi, Guido
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 1-gen-2008 Takahara, T; Xue, F; Mazzone, M; Yata, Y; Nonome, K; Kanayama, M; Kawai, K; Pisacane, Am; Takahara, S; Li, Xk; Comoglio, Paolo; Sugiyama, T; Michieli, Paolo
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 1-gen-2008 Takahara, T; Xue, F; Mazzone, M; Yata, Y; Nonome, K; Kanayama, M; Kawai, K; Pisacane, Am; Takahara, S; Li, Xk; Comoglio, Pm; Sugiyama, T; Michieli, P
Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells 1-gen-2019 Carotenuto, P; Hedayat, S; Fassan, M; Cardinale, V; Lampis, A; Guzzardo, V; Vicentini, C; Scarpa, A; Cascione, L; Costantini, D; Carpino, G; Alvaro, D; Ghidini, M; Trevisani, F; Te Poele, R; Salati, M; Ventura, S; Vlachogiannis, G; Hahne, Jc; Boulter, L; Forbes, Sj; Guest, R; Cillo, U; Said-Huntingford, I; Begum, R; Smyth, E; Michalarea, V; Cunningham, D; Rimassa, L; Santoro, A; Roncalli, M; Kirnkin, V; Clarke, P; Workman, P; Valeri, N; Braconi, C
Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies 1-gen-2000 Maggioni, M; Coggi, G; Cassani, B; Bianchi, P; Romagnoli, S; Mandelli, A; Borzio, M; Colombo, P; Roncalli, M
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 1-gen-2017 Ng, KIU YAN CHARLOTTE; Piscuoglio, Salvatore; Terracciano, Luigi M
A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis 1-gen-2012 D'Ambrosio, R; Aghemo, A; Rumi, Mg; Ronchi, G; Donato, Mf; Paradis, V; Colombo, M; Bedossa, P
Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18 1-gen-2017 Ravà, Micol; D'Andrea, Aleco; Doni, Mirko; Kress, Theresia R.; Ostuni, Renato; Bianchi, Valerio; Morelli, Marco J.; Collino, Agnese; Ghisletti, Serena; Nicoli, Paola; Recordati, Camilla; Iascone, Maria; Sonzogni, Aurelio; D'Antiga, Lorenzo; Shukla, Ruchi; Faulkner, Geoffrey J.; Natoli, Gioacchino; Campaner, Stefano; Amati, Bruno
Natural NS3, NS5A and NS5B HCV resistance is common in real practice, differently associated to HCV genotypes and response to NS5A inhibitors 1-gen-2016 Cento, V; Sorbo, Mc; Bertoli, A; Lenci, I; Polilli, E; Masetti, C; Gianserra, L; Teti, E; Biliotti, E; Magni, Cf; Aragri, M; Micheli, V; Melis, M; Nicolini, La; Marenco, S; Calvaruso, V; Paolucci, S; Baldanti, F; Morisco, F; Siciliano, M; Palitti, Vp; Andreone, P; Bruzzone, B; Coppola, N; Ruggiero, T; Lichtner, M; Menzaghi, B; Romagnoli, D; Iapadre, N; Di Maio, Vc; De Leonardis, F; Milana, M; Cacciatore, P; Pieri, A; Sarmati, L; Landonio, S; Gasbarrini, A; Puoti, M; Craxi, A; Vullo, V; Pellicelli, Am; Babudieri, S; Rizzardini, G; Taliani, G; Andreoni, M; Pasquazzi, C; Parruti, G; Angelico, M; Perno, Cf; Ceccherini-Silberstein, F
New horizons in hepatitis C antiviral therapy with direct-acting antivirals 1-gen-2013 Aghemo, A; De Francesco, R
NPLA3 I148M polymorphism, steatosis, liver damage, and treatment response in chronic hepatitis C 1-gen-2010 Valenti, L. V. C.; Rumi, M.; Galmozzi, E.; Del Menico, B.; De Nicola, S.; Dongiovanni, P.; Maggioni, M.; Fracanzani, A. L.; Rametta, R.; Colombo, M.; Fargion, S. R.; Aghemo, A. M.
Mostrati risultati da 64 a 83 di 123
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile